Creatine therapy to improve neurobehavioural function in obstructive sleep apnea
This study will test the treatment effectiveness of creatine supplementation to improve neurobehavioural performance in obstructive sleep apnea
Obstructive sleep apnea (OSA) is a well established cause of sleepiness and daytime dysfunction. OSA patients exhibit varying levels of performance deficits in memory, attention, executive function and vigilance tasks. In addition, brain imaging studies of OSA patients have reported neurobiological abnormalities. Creatine plays a pivotal role in the brain and there is excellent preliminary data demonstrating its value as a neuroprotective agent. Creatine supplementation results in improved cognitive performance, increased cerebral perfusion, improved brain energetics and is neuroprotective in hypoxia.
This project will determine whether a simple therapy, creatine supplementation, improves brain function measured by neurobehavioural and cognitive testing in OSA.
This project would also be suitable for an Honours candidate.
Want to find out more?
Contact us to find out what’s involved in applying for a PhD.
Contact Research Expert to find out more about participating in this opportunity.
Browse for other opportunities within the Camperdown - Woolcock Institute of Medical Research .
The opportunity ID for this research opportunity is: 1121
Other opportunities with Professor Ron Grunstein
- Chronotherapy for hypertension in obstructive sleep apnea
- The effect of modafinil on daytime sleepiness, neurobehavioural performance and quality of life in obstructive sleep apnea patients
- Which sleep apnea patients have problems with alertness and attention?
- Developing a psychoeducation program to improve sleep-wake disturbances in Parkinson’s Disease